EMHIGLO

Welcome to the Brand page for “EMHIGLO”, which is offered here for Blood plasma derivatives and immunoglobulin preparations for therapeutic treatment against covid-19;.

Its status is currently believed to be active. Its class is unavailable. “EMHIGLO” is believed to be currently owned by “EMERGENT BIOSOLUTIONS CANADA INC.”

Owner:
EMERGENT BIOSOLUTIONS CANADA INC.
Owner Details
Description:
Blood plasma derivatives and immunoglobulin preparations for therapeutic treatment against COVID-19;
Categories: BLOOD PLASMA DERIVATIVES IMMUNOGLOBULIN